The role of MMP-9 and MMP-12 inhibitors in inflammation

Tim Cawston, Severine Carrere, Jon Catterall, Richard Duggleby, Sarah Elliott, Bill Shingleton, Andrew Rowan, Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease. Novartis Foundation Symposium 234: Chronic Obstructive Pulmonary Disease: Pathogenesis to Treatment. ,vol. 234, pp. 205- 228 ,(2001) , 10.1002/0470868678.CH13

Philippe E. Van den Steen, Paul Proost, Anja Wuyts, Jo Van Damme, Ghislain Opdenakker, Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact Blood. ,vol. 96, pp. 2673- 2681 ,(2000) , 10.1182/BLOOD.V96.8.2673

Eli Breuer, Julia Frant, Reuven Reich, Recent non-hydroxamate matrix metalloproteinase inhibitors Expert Opinion on Therapeutic Patents. ,vol. 15, pp. 253- 269 ,(2005) , 10.1517/13543776.15.3.253

SJ Urbanski, DR Edwards, A Maitland, KJ Leco, A Watson, AE Kossakowska, Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. British Journal of Cancer. ,vol. 66, pp. 1188- 1194 ,(1992) , 10.1038/BJC.1992.434

Moisés Selman, José Cisneros-Lira, Miguel Gaxiola, Remedios Ramírez, Elizabeth M. Kudlacz, Peter G. Mitchell, Annie Pardo, Matrix Metalloproteinases Inhibition Attenuates Tobacco Smoke-Induced Emphysema in Guinea Pigs Chest. ,vol. 123, pp. 1633- 1641 ,(2003) , 10.1378/CHEST.123.5.1633

Erik Martens, An Leyssen, Ilse Van Aelst, Pierre Fiten, Helene Piccard, Jialiang Hu, Francis J. Descamps, Philippe E. Van den Steen, Paul Proost, Jo Van Damme, Grazia Maria Liuzzi, Paolo Riccio, Eugenia Polverini, Ghislain Opdenakker, A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains Biochimica et Biophysica Acta. ,vol. 1770, pp. 178- 186 ,(2007) , 10.1016/J.BBAGEN.2006.10.012

William C. Parks, Carole L. Wilson, Yolanda S. López-Boado, Matrix metalloproteinases as modulators of inflammation and innate immunity Nature Reviews Immunology. ,vol. 4, pp. 617- 629 ,(2004) , 10.1038/NRI1418

M. Hidalgo, S. G. Eckhardt, Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy Journal of the National Cancer Institute. ,vol. 93, pp. 178- 193 ,(2001) , 10.1093/JNCI/93.3.178

Elisabeth I. Heath, Barbara A. Burtness, Lawrence Kleinberg, Ronald R. Salem, Stephen C. Yang, Richard F. Heitmiller, Marcia I. Canto, Jonathan P. S. Knisely, Mark Topazian, Elizabeth Montgomery, Nancy Tsottles, Yazdi Pithavala, Bridget Rohmiller, Mary Collier, Arlene A. Forastiere, Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma Investigational New Drugs. ,vol. 24, pp. 135- 140 ,(2006) , 10.1007/S10637-006-5934-5

Philippe E. Van den Steen, Anja Wuyts, Steven J. Husson, Paul Proost, Jo Van Damme, Ghislain Opdenakker, Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. FEBS Journal. ,vol. 270, pp. 3739- 3749 ,(2003) , 10.1046/J.1432-1033.2003.03760.X